Evogene Ltd. EVGN announced today a key milestone in its insect control program with the
successful completion of the first computational discovery round for
microbial genes with insecticidal properties. The discovery round
utilized a unique computational technology infrastructure consisting of
a proprietary microbial-based database and a dedicated analysis
platform, BiomeMinerTM. The candidate genes will be validated
against target insects at the Company's dedicated R&D site located in
St. Louis, Missouri. Validation is expected to be completed next year.
The first computational discovery round using BiomeMinerTM
yielded a set of novel candidate genes with insecticidal properties to
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in